Exercise Reduces Sleep Problems in Breast Cancer Survivors

Share this content:
Exercise Reduces Sleep Problems in Breast Cancer Survivors
Exercise Reduces Sleep Problems in Breast Cancer Survivors

TUESDAY, Dec. 26, 2017 (HealthDay News) -- A physical activity intervention reduces perceived sleep dysfunction at three and six months for post-primary treatment breast cancer survivors, according to a study published recently in Medicine & Science in Sports & Exercise.

Laura Q. Rogers, M.D., M.P.H., from the University of Alabama at Birmingham, and colleagues examined the effects of a physical activity behavior change intervention on sleep quality in a sample of 222 post-primary treatment breast cancer survivors. The survivors were randomized to a three-month physical activity behavior change intervention (Better Exercise Adherence after Treatment for Cancer [BEAT Cancer]) or usual care.

The researchers found that BEAT Cancer significantly improved Pittsburgh Sleep Quality Index [PSQI] global sleep quality compared with usual care after adjustment for covariates at three and six months (mean between-group difference, −1.4 and −1.0, respectively). At three months, but not at six months, BEAT Cancer improved several PSQI subscales (sleep quality, sleep disturbances, and daytime dysfunction; mean between-group difference, −0.3, −0.2, and −0.2, respectively). There was a nonsignificant increase in the percentage of participants classified as good sleepers. Accelerometer latency and efficiency did not differ significantly between the groups.

"A physical activity intervention significantly reduced perceived global sleep dysfunction at three and six months, primarily because of improvements in sleep quality aspects not detected with accelerometer," the authors write.

Abstract/Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease



Sign up for myCME e-newsletters


More in Home

FDA Approves First Drug for Rare Form of Rickets

FDA Approves First Drug for Rare Form of ...

Crysvita approved for adults and children ages 1 year and older with x-linked hypophosphatemia

High FGF-23 Linked to Recurrent Cardiac Events After ACS

High FGF-23 Linked to Recurrent Cardiac Events After ...

FGF-23 in top quartile independently linked to greater risk of CV death, heart failure hospitalization

Medical Cannabis Not Recommended for Sleep Apnea

Medical Cannabis Not Recommended for Sleep Apnea

American Academy of Sleep Medicine says evidence insufficient to recommend cannabis for apnea

is free, fast, and customized just for you!

Already a member?

Sign In Now »